ResMed (RMD) Reports In-Line Q1 EPS
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $191.26 +1.49%
EPS Growth %: +13.3%
Financial Fact:
Diluted weighted average shares outstanding: 142.09M
Today's EPS Names:
CBRS, MAYS, CRMT, More
EPS Growth %: +13.3%
Financial Fact:
Diluted weighted average shares outstanding: 142.09M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q1 EPS of $1.51, in-line with the analyst estimate of $1.51. Revenue for the quarter came in at $950.3 million versus the consensus estimate of $947.96 million.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- FedEx (FDX) Tops Q4 EPS by 39c, Beats on Revenue; Offers FY27 EPS Guidance
- CVG to join Russell 2000 and Russell 3000 indexes June 26
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
